Gestational diabetes and childhood asthma in a racially diverse US pregnancy cohort.


Journal

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718

Informations de publication

Date de publication:
08 2021
Historique:
revised: 16 04 2021
received: 30 11 2020
pubmed: 25 4 2021
medline: 5 10 2021
entrez: 24 4 2021
Statut: ppublish

Résumé

Childhood asthma is a common chronic disease that likely has prenatal origins. Gestational diabetes alters maternal physiology and may influence fetal risk for childhood-onset disease. However, the association between gestational diabetes and child asthma is not well characterized. To investigate the association between gestational diabetes and wheeze/asthma at approximately 4 years of age in a racially diverse US cohort. We studied mother-child dyads enrolled prenatally in the Conditions Affecting Neurocognitive Development and Learning in Early Childhood study. Gestational diabetes was determined by medical chart review. At approximately 4 years of age, we assessed child respiratory outcomes including parent report of physician-diagnosed asthma (ever), current wheeze (symptoms within the past 12 months), and current asthma (physician diagnosis and/or medication or symptoms within the past 12 months). We used the modified Poisson regression to assess associations between gestational diabetes and child respiratory outcomes, adjusting for maternal age, race, prenatal smoking, pre-pregnancy body mass index, parity, asthma history, socioeconomic status, and infant sex. Among 1107 women, 66% were African American/Black. Six percent (n = 62) had gestational diabetes documented during pregnancy. Gestational diabetes was associated with increased risk of physician-diagnosed asthma (adjusted risk ratio (RR) [95% Confidence Interval]: 2.13 [1.35, 3.38]; prevalence: 14%), current wheeze (RR: 1.85 [1.23, 2.78]; prevalence: 19%), and current asthma (RR: 2.01 [1.30, 3.10]; prevalence: 16%). Gestational diabetes was associated with increased risk of asthma and wheeze outcomes. Additional studies are needed to elucidate modifiable pathways underlying this association.

Sections du résumé

BACKGROUND
Childhood asthma is a common chronic disease that likely has prenatal origins. Gestational diabetes alters maternal physiology and may influence fetal risk for childhood-onset disease. However, the association between gestational diabetes and child asthma is not well characterized.
OBJECTIVE
To investigate the association between gestational diabetes and wheeze/asthma at approximately 4 years of age in a racially diverse US cohort.
METHODS
We studied mother-child dyads enrolled prenatally in the Conditions Affecting Neurocognitive Development and Learning in Early Childhood study. Gestational diabetes was determined by medical chart review. At approximately 4 years of age, we assessed child respiratory outcomes including parent report of physician-diagnosed asthma (ever), current wheeze (symptoms within the past 12 months), and current asthma (physician diagnosis and/or medication or symptoms within the past 12 months). We used the modified Poisson regression to assess associations between gestational diabetes and child respiratory outcomes, adjusting for maternal age, race, prenatal smoking, pre-pregnancy body mass index, parity, asthma history, socioeconomic status, and infant sex.
RESULTS
Among 1107 women, 66% were African American/Black. Six percent (n = 62) had gestational diabetes documented during pregnancy. Gestational diabetes was associated with increased risk of physician-diagnosed asthma (adjusted risk ratio (RR) [95% Confidence Interval]: 2.13 [1.35, 3.38]; prevalence: 14%), current wheeze (RR: 1.85 [1.23, 2.78]; prevalence: 19%), and current asthma (RR: 2.01 [1.30, 3.10]; prevalence: 16%).
CONCLUSIONS
Gestational diabetes was associated with increased risk of asthma and wheeze outcomes. Additional studies are needed to elucidate modifiable pathways underlying this association.

Identifiants

pubmed: 33894077
doi: 10.1111/pai.13523
pmc: PMC8328913
mid: NIHMS1707854
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1190-1196

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL109977
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024975
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL150312
Pays : United States

Informations de copyright

© 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Références

J Pediatr. 2020 Apr;219:173-179.e1
pubmed: 31987655
Part Fibre Toxicol. 2013 Jul 16;10:29
pubmed: 23856009
J Allergy Clin Immunol. 2020 Mar;145(3):800-807.e4
pubmed: 31809758
Allergy. 2018 Nov;73(11):2247-2250
pubmed: 29987908
Int J Epidemiol. 2015 Feb;44(1):199-208
pubmed: 25626439
Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 2):e733-9
pubmed: 20444150
Thorax. 2007 Aug;62(8):714-7
pubmed: 17356057
Am J Obstet Gynecol. 1991 Dec;165(6 Pt 1):1667-72
pubmed: 1750458
Biomed Res Int. 2014;2014:418975
pubmed: 24967364
Am J Epidemiol. 2011 Feb 1;173(3):310-8
pubmed: 21190986
Int J Mol Sci. 2018 Oct 26;19(11):
pubmed: 30373146
Semin Fetal Neonatal Med. 2012 Apr;17(2):82-91
pubmed: 22265927
Allergy. 1999;54 Suppl 49:62-7
pubmed: 10422750
BJOG. 2017 Apr;124(5):804-813
pubmed: 27510598
Pediatrics. 2016 Jan;137(1):
pubmed: 26712860
Obstet Gynecol. 2018 Feb;131(2):e49-e64
pubmed: 29370047
Pediatr Allergy Immunol. 2018 Mar;29(2):144-150
pubmed: 29168294
Am J Respir Crit Care Med. 2007 Jan 1;175(1):16-21
pubmed: 16998092
J Allergy Clin Immunol. 2009 Nov;124(5):1031-8.e1-4
pubmed: 19733904
Eur Respir J. 1995 Mar;8(3):483-91
pubmed: 7789502
Pediatr Allergy Immunol. 2007 Jun;18(4):313-9
pubmed: 17346296
J Diabetes Complications. 2016 Sep-Oct;30(7):1393-400
pubmed: 27230834
Eur J Pediatr. 2016 Jun;175(6):799-808
pubmed: 26898703
Biochem J. 2016 Dec 15;473(24):4527-4550
pubmed: 27941030
Clin Exp Pharmacol Physiol. 2013 Nov;40(11):803-16
pubmed: 24033542
Paediatr Respir Rev. 2017 Jan;21:19-26
pubmed: 27665512
J Matern Fetal Neonatal Med. 2019 Feb;32(4):687-694
pubmed: 28969466
BJOG. 2009 Dec;116(13):1729-35
pubmed: 19832834
In Vivo. 2019 Jan-Feb;33(1):31-40
pubmed: 30587599

Auteurs

Margaret A Adgent (MA)

Division of General Pediatrics, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, USA.

Tebeb Gebretsadik (T)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Jada Reedus (J)

Division of General Pediatrics, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Meharry Medical College, Nashville, TN, USA.

Cornelia Graves (C)

University of Tennessee Health Sciences Center, College of Medicine, Nashville and Tennessee Maternal Fetal Medicine, Nashville, TN, USA.

Etoi Garrison (E)

Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA.

Nicole Bush (N)

Department of Psychiatry, University of California, San Francisco, CA, USA.
Department of Pediatrics, University of California, San Francisco, CA, USA.

Robert Davis (R)

Center for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, TN, USA.

Kaja Z LeWinn (KZ)

Department of Psychiatry, University of California, San Francisco, CA, USA.

Frances Tylavsky (F)

Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

Kecia N Carroll (KN)

Division of General Pediatrics, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH